Want to see TSE:ASIA full AI Analyst Report?
ASIA Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.02
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
C$543.71K
Enterprise ValueC$779.80K
Total Cash (Recent Filing)C$198.00
Total Debt (Recent Filing)C$237.41K
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding36,247,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-0.78
Price to Sales (P/S)0.00
P/FCF Ratio-10.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Innovative Product OfferingASIA's focus on innovative plant-based technologies positions it well in sustainable agriculture, potentially driving long-term demand.
Strategic PartnershipsStrategic partnerships for R&D and licensing can enhance ASIA's market reach and innovation capabilities, supporting growth.
Sustainable Agriculture FocusASIA's commitment to sustainable agriculture aligns with global trends, potentially attracting eco-conscious customers and partners.
Bears Say
Severe Financial DistressThe lack of revenue and high operational losses indicate severe financial distress, threatening long-term viability without a turnaround.
Negative Cash FlowPersistent negative cash flow suggests ongoing liquidity issues, limiting ASIA's ability to invest in growth or sustain operations.
Weak Balance SheetA weak balance sheet with high leverage poses solvency risks, potentially hampering ASIA's financial stability and growth prospects.
Asia Green Biotechnology Corp. News
ASIA FAQ
What was Asia Green Biotechnology Corp.’s price range in the past 12 months?
Asia Green Biotechnology Corp. lowest stock price was C$0.01 and its highest was C$0.01 in the past 12 months.
What is Asia Green Biotechnology Corp.’s market cap?
Asia Green Biotechnology Corp.’s market cap is C$543.71K.
When is Asia Green Biotechnology Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Asia Green Biotechnology Corp.’s earnings last quarter?
Currently, no data Available
Is Asia Green Biotechnology Corp. overvalued?
According to Wall Street analysts Asia Green Biotechnology Corp.’s price is currently Overvalued.
Does Asia Green Biotechnology Corp. pay dividends?
Asia Green Biotechnology Corp. does not currently pay dividends.
What is Asia Green Biotechnology Corp.’s EPS estimate?
Asia Green Biotechnology Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Asia Green Biotechnology Corp. have?
Asia Green Biotechnology Corp. has 36,247,100 shares outstanding.
What happened to Asia Green Biotechnology Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Asia Green Biotechnology Corp.?
Currently, no hedge funds are holding shares in TSE:ASIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Asia Green Biotechnology Corp.
Asia Green Biotechnology Corp. is an emerging international biotechnology firm dedicated to researching, developing, testing, and distributing products. These offerings leverage the company's proprietary organic hybridization technology, with its primary application focused in Asia. A key aspect of their operations involves the cultivation and harvesting of novel and commercially valuable strains of hemp and similar crops. The company has forged strategic alliances with Pathway Rx Inc. and PNW Biosciences Inc. to advance the clinical development and market introduction of specific Cannabis sativa varieties. These varieties are being explored for their potential in both preventing and treating COVID-19 and other infectious ailments. Established in 2017, the organization was originally named Asia Cannabis Corp. It adopted its current moniker, Asia Green Biotechnology Corp., in April 2020. Its corporate headquarters are located in Calgary, Canada.